"The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting.
Diclegis is a delayed-release tablet intended for women who have"...
Niferex®-150 Forte is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.
Niferex®-150 Forte Capsules are red and clear capsules filled with brown powder, imprinted in white ink with "THX" on the cap and "164" on the body, in bottles of 90 capsules (NDC 64011-164-26).
Store at 25°C (77°F); excursions permitted to 15° - 30°C (59° - 86°F). [See USP Controlled Room Temperature.] Avoid excessive heat 40°C (104°F). Avoid freezing.
Mktd. by Ther-Rx Corp., St. Louis, MO 63044. 05/06. FDA rev date: n/a
Last reviewed on RxList: 8/15/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Niferex-150 Forte Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Parenting and Pregnancy
Get tips for baby and you.